Annotation Detail for CECR5

Basic Information
Top
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of CECR5 mRNA | affects expression | 21346803
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CECR5 mRNA | affects binding|increases activity|increases expression | 19710929
|
D014303 |
Trinitrotoluene |
Trinitrotoluene affects the expression of CECR5 mRNA | affects expression | 21346803
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Trinitrotoluene |
4.93 | 7525203 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.64 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
4.22 | 16434500 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.63 | 19483382 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
1.79 | 16705839 |
MESH:D002386 |
Cataract |
|
Trinitrotoluene |
4.10 | 14694615 15817613 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.15 | 19176532 |
MESH:D000013 |
Congenital Abnormalities |
|
Trinitrotoluene |
4.82 | 15095906 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
13.50 | 18551238 |
MESH:D003490 |
Cyanosis |
|
Trinitrotoluene |
13.50 | 18551238 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.59 | 18249437 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
4.52 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Trinitrotoluene |
4.52 | 18551238 21346803 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.96 | 12083418 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
3.25 | 19236843 20131406 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.78 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
11.02 | 19772884 16221962 19176532 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Trinitrotoluene |
11.02 | 15817613 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.63 | 20558911 |
MESH:D007248 |
Infertility, Male |
|
Trinitrotoluene |
3.95 | 12150543 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.90 | 16306350 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
3.36 | 16705839 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
1.94 | 15890375 16377806 20007298 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
4.16 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.29 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.29 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
13.29 | 18551238 |
MESH:D009336 |
Necrosis |
|
Trinitrotoluene |
13.29 | 18551238 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.12 | 17405874 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.89 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
10.74 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
Trinitrotoluene |
10.74 | 12819281 14694615 17852074 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.56 | 19058328 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
7.17 | 18551238 |
MESH:D012640 |
Seizures |
|
Trinitrotoluene |
7.17 | 18551238 |
MESH:D013163 |
Splenomegaly |
|
Trinitrotoluene |
5.85 | 15817613 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
2.42 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
5.06 | 10091137 |